Acute coronary syndrome.
Acute coronary syndrome (ACS) is the umbrella term for the clinical signs and symptoms of myocardial ischemia: unstable angina, non-ST-segment elevation myocardial infarction, and ST-segment elevation myocardial infarction. This article further defines ACS and the conditions it includes; reviews its risk factors; describes its pathophysiology and associated signs and symptoms; discusses variations in its diagnostic findings, such as cardiac biomarkers and electrocardiographic changes; and outlines treatment approaches, including drug and reperfusion therapies.
Overbaugh
Kristen J
KJ
Central New Mexico Community College, Albuquerque, USA. koverbaugh@cnm.edu
D054058:Acute Coronary Syndrome / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D000701:Analgesics, Opioid / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D052279:Creatine Kinase, MB Form / Q000097:blood; D004562:Electrocardiography; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D009020:Morphine / Q000627:therapeutic use; D009204:Myocardial Revascularization / Q000379:methods; D005996:Nitroglycerin / Q000627:therapeutic use; D024802:Nurse's Role; D009730:Nursing Assessment; D010102:Oxygen Inhalation Therapy; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D012307:Risk Factors; D014336:Troponin; D014665:Vasodilator Agents / Q000627:therapeutic use
D000701:Analgesics, Opioid; D000806:Angiotensin-Converting Enzyme Inhibitors; D015415:Biomarkers; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors; D014336:Troponin; D014665:Vasodilator Agents; D009020:Morphine; D052279:Creatine Kinase, MB Form; D005996:Nitroglycerin; D001241:Aspirin